Resources & Information

The North Carolina Medical Board has named Thomas W. Mansfield, JD, as its new Chief Executive Officer. Prior to accepting the position of CEO, Mr. Mansfield served as the organization’s Chief…

In North Carolina and across the nation, the veterinary sedative xylazine is increasingly detected in the illicit opioid drug supply and in opioid overdoses. Toxicology data from major US regions…

NCMB has received inquiries about a new federal training requirement that affects all prescribers with a valid DEA registration, regardless of whether they prescribe opioids or treat patients with…